Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Identifieur interne : 000E62 ( Ncbi/Curation ); précédent : 000E61; suivant : 000E63Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Auteurs : Wenhui Li ; Chengsheng Zhang ; Jianhua Sui ; Jens H. Kuhn ; Michael J. Moore ; Shiwen Luo ; Swee-Kee Wong ; I-Chueh Huang ; Keming Xu ; Natalya Vasilieva ; Akikazu Murakami ; Yaqing He ; Wayne A. Marasco ; Yi Guan ; Hyeryun Choe ; Michael FarzanSource :
- The EMBO Journal [ 0261-4189 ] ; 2005.
Descripteurs français
- KwdFr :
- Alignement de séquences, Animaux, Carboxypeptidases (), Carboxypeptidases (génétique), Carboxypeptidases (métabolisme), Domaine catalytique, Données de séquences moléculaires, Flambées de maladies, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (métabolisme), Humains, Liaison aux protéines, Modèles moléculaires, Peptidyl-Dipeptidase A, Protéines de fusion recombinantes (génétique), Protéines de fusion recombinantes (métabolisme), Protéines de l'enveloppe virale (métabolisme), Rats, Sites de fixation, Structure tertiaire des protéines, Syndrome respiratoire aigu sévère (virologie), Syndrome respiratoire aigu sévère (épidémiologie), Séquence d'acides aminés, Virus du SRAS (métabolisme), Viverridae (virologie).
- MESH :
- génétique : Carboxypeptidases, Protéines de fusion recombinantes.
- métabolisme : Carboxypeptidases, Glycoprotéines membranaires, Protéines de fusion recombinantes, Protéines de l'enveloppe virale, Virus du SRAS.
- virologie : Syndrome respiratoire aigu sévère, Viverridae.
- épidémiologie : Syndrome respiratoire aigu sévère.
- Alignement de séquences, Animaux, Carboxypeptidases, Domaine catalytique, Données de séquences moléculaires, Flambées de maladies, Glycoprotéine de spicule des coronavirus, Humains, Liaison aux protéines, Modèles moléculaires, Peptidyl-Dipeptidase A, Rats, Sites de fixation, Structure tertiaire des protéines, Séquence d'acides aminés.
English descriptors
- KwdEn :
- Amino Acid Sequence, Animals, Binding Sites, Carboxypeptidases (chemistry), Carboxypeptidases (genetics), Carboxypeptidases (metabolism), Catalytic Domain, Disease Outbreaks, Humans, Membrane Glycoproteins (metabolism), Models, Molecular, Molecular Sequence Data, Peptidyl-Dipeptidase A, Protein Binding, Protein Structure, Tertiary, Rats, Recombinant Fusion Proteins (genetics), Recombinant Fusion Proteins (metabolism), SARS Virus (metabolism), Sequence Alignment, Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (virology), Spike Glycoprotein, Coronavirus, Viral Envelope Proteins (metabolism), Viverridae (virology).
- MESH :
- chemical , chemistry : Carboxypeptidases.
- chemical , genetics : Carboxypeptidases, Recombinant Fusion Proteins.
- chemical , metabolism : Carboxypeptidases, Membrane Glycoproteins, Recombinant Fusion Proteins, Viral Envelope Proteins.
- epidemiology : Severe Acute Respiratory Syndrome.
- metabolism : SARS Virus.
- virology : Severe Acute Respiratory Syndrome, Viverridae.
- Amino Acid Sequence, Animals, Binding Sites, Catalytic Domain, Disease Outbreaks, Humans, Models, Molecular, Molecular Sequence Data, Peptidyl-Dipeptidase A, Protein Binding, Protein Structure, Tertiary, Rats, Sequence Alignment, Spike Glycoprotein, Coronavirus.
Abstract
Human angiotensin‐converting enzyme 2 (ACE2) is a functional receptor for SARS coronavirus (SARS‐CoV). Here we identify the SARS‐CoV spike (S)‐protein‐binding site on ACE2. We also compare S proteins of SARS‐CoV isolated during the 2002–2003 SARS outbreak and during the much less severe 2003–2004 outbreak, and from palm civets, a possible source of SARS‐CoV found in humans. All three S proteins bound to and utilized palm‐civet ACE2 efficiently, but the latter two S proteins utilized human ACE2 markedly less efficiently than did the S protein obtained during the earlier human outbreak. The lower affinity of these S proteins could be complemented by altering specific residues within the S‐protein‐binding site of human ACE2 to those of civet ACE2, or by altering S‐protein residues 479 and 487 to residues conserved during the 2002–2003 outbreak. Collectively, these data describe molecular interactions important to the adaptation of SARS‐CoV to human cells, and provide insight into the severity of the 2002–2003 SARS epidemic.
Url:
DOI: 10.1038/sj.emboj.7600640
PubMed: 15791205
PubMed Central: 1142572
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F31
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000F31
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001261
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002820
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002820
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002545
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000E62
Links to Exploration step
PMC:1142572Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2</title><author><name sortKey="Li, Wenhui" sort="Li, Wenhui" uniqKey="Li W" first="Wenhui" last="Li">Wenhui Li</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Zhang, Chengsheng" sort="Zhang, Chengsheng" uniqKey="Zhang C" first="Chengsheng" last="Zhang">Chengsheng Zhang</name><affiliation><nlm:aff id="embj7600640-aff-0002"></nlm:aff></affiliation><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Sui, Jianhua" sort="Sui, Jianhua" uniqKey="Sui J" first="Jianhua" last="Sui">Jianhua Sui</name><affiliation><nlm:aff id="embj7600640-aff-0004"></nlm:aff></affiliation></author><author><name sortKey="Kuhn, Jens H" sort="Kuhn, Jens H" uniqKey="Kuhn J" first="Jens H" last="Kuhn">Jens H. Kuhn</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation><affiliation><nlm:aff id="embj7600640-aff-0005"></nlm:aff></affiliation></author><author><name sortKey="Moore, Michael J" sort="Moore, Michael J" uniqKey="Moore M" first="Michael J" last="Moore">Michael J. Moore</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Luo, Shiwen" sort="Luo, Shiwen" uniqKey="Luo S" first="Shiwen" last="Luo">Shiwen Luo</name><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Wong, Swee Ee" sort="Wong, Swee Ee" uniqKey="Wong S" first="Swee-Kee" last="Wong">Swee-Kee Wong</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Huang, I Hueh" sort="Huang, I Hueh" uniqKey="Huang I" first="I-Chueh" last="Huang">I-Chueh Huang</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Xu, Keming" sort="Xu, Keming" uniqKey="Xu K" first="Keming" last="Xu">Keming Xu</name><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Vasilieva, Natalya" sort="Vasilieva, Natalya" uniqKey="Vasilieva N" first="Natalya" last="Vasilieva">Natalya Vasilieva</name><affiliation><nlm:aff id="embj7600640-aff-0006"></nlm:aff></affiliation></author><author><name sortKey="Murakami, Akikazu" sort="Murakami, Akikazu" uniqKey="Murakami A" first="Akikazu" last="Murakami">Akikazu Murakami</name><affiliation><nlm:aff id="embj7600640-aff-0004"></nlm:aff></affiliation></author><author><name sortKey="He, Yaqing" sort="He, Yaqing" uniqKey="He Y" first="Yaqing" last="He">Yaqing He</name><affiliation><nlm:aff id="embj7600640-aff-0007"></nlm:aff></affiliation></author><author><name sortKey="Marasco, Wayne A" sort="Marasco, Wayne A" uniqKey="Marasco W" first="Wayne A" last="Marasco">Wayne A. Marasco</name><affiliation><nlm:aff id="embj7600640-aff-0004"></nlm:aff></affiliation></author><author><name sortKey="Guan, Yi" sort="Guan, Yi" uniqKey="Guan Y" first="Yi" last="Guan">Yi Guan</name><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Choe, Hyeryun" sort="Choe, Hyeryun" uniqKey="Choe H" first="Hyeryun" last="Choe">Hyeryun Choe</name><affiliation><nlm:aff id="embj7600640-aff-0006"></nlm:aff></affiliation></author><author><name sortKey="Farzan, Michael" sort="Farzan, Michael" uniqKey="Farzan M" first="Michael" last="Farzan">Michael Farzan</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">15791205</idno><idno type="pmc">1142572</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142572</idno><idno type="RBID">PMC:1142572</idno><idno type="doi">10.1038/sj.emboj.7600640</idno><date when="2005">2005</date><idno type="wicri:Area/Pmc/Corpus">000F31</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000F31</idno><idno type="wicri:Area/Pmc/Curation">000F31</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000F31</idno><idno type="wicri:Area/Pmc/Checkpoint">001261</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001261</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15791205</idno><idno type="wicri:Area/PubMed/Corpus">002820</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002820</idno><idno type="wicri:Area/PubMed/Curation">002820</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002820</idno><idno type="wicri:Area/PubMed/Checkpoint">002545</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002545</idno><idno type="wicri:Area/Ncbi/Merge">000E62</idno><idno type="wicri:Area/Ncbi/Curation">000E62</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2</title><author><name sortKey="Li, Wenhui" sort="Li, Wenhui" uniqKey="Li W" first="Wenhui" last="Li">Wenhui Li</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Zhang, Chengsheng" sort="Zhang, Chengsheng" uniqKey="Zhang C" first="Chengsheng" last="Zhang">Chengsheng Zhang</name><affiliation><nlm:aff id="embj7600640-aff-0002"></nlm:aff></affiliation><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Sui, Jianhua" sort="Sui, Jianhua" uniqKey="Sui J" first="Jianhua" last="Sui">Jianhua Sui</name><affiliation><nlm:aff id="embj7600640-aff-0004"></nlm:aff></affiliation></author><author><name sortKey="Kuhn, Jens H" sort="Kuhn, Jens H" uniqKey="Kuhn J" first="Jens H" last="Kuhn">Jens H. Kuhn</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation><affiliation><nlm:aff id="embj7600640-aff-0005"></nlm:aff></affiliation></author><author><name sortKey="Moore, Michael J" sort="Moore, Michael J" uniqKey="Moore M" first="Michael J" last="Moore">Michael J. Moore</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Luo, Shiwen" sort="Luo, Shiwen" uniqKey="Luo S" first="Shiwen" last="Luo">Shiwen Luo</name><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Wong, Swee Ee" sort="Wong, Swee Ee" uniqKey="Wong S" first="Swee-Kee" last="Wong">Swee-Kee Wong</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Huang, I Hueh" sort="Huang, I Hueh" uniqKey="Huang I" first="I-Chueh" last="Huang">I-Chueh Huang</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Xu, Keming" sort="Xu, Keming" uniqKey="Xu K" first="Keming" last="Xu">Keming Xu</name><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Vasilieva, Natalya" sort="Vasilieva, Natalya" uniqKey="Vasilieva N" first="Natalya" last="Vasilieva">Natalya Vasilieva</name><affiliation><nlm:aff id="embj7600640-aff-0006"></nlm:aff></affiliation></author><author><name sortKey="Murakami, Akikazu" sort="Murakami, Akikazu" uniqKey="Murakami A" first="Akikazu" last="Murakami">Akikazu Murakami</name><affiliation><nlm:aff id="embj7600640-aff-0004"></nlm:aff></affiliation></author><author><name sortKey="He, Yaqing" sort="He, Yaqing" uniqKey="He Y" first="Yaqing" last="He">Yaqing He</name><affiliation><nlm:aff id="embj7600640-aff-0007"></nlm:aff></affiliation></author><author><name sortKey="Marasco, Wayne A" sort="Marasco, Wayne A" uniqKey="Marasco W" first="Wayne A" last="Marasco">Wayne A. Marasco</name><affiliation><nlm:aff id="embj7600640-aff-0004"></nlm:aff></affiliation></author><author><name sortKey="Guan, Yi" sort="Guan, Yi" uniqKey="Guan Y" first="Yi" last="Guan">Yi Guan</name><affiliation><nlm:aff id="embj7600640-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Choe, Hyeryun" sort="Choe, Hyeryun" uniqKey="Choe H" first="Hyeryun" last="Choe">Hyeryun Choe</name><affiliation><nlm:aff id="embj7600640-aff-0006"></nlm:aff></affiliation></author><author><name sortKey="Farzan, Michael" sort="Farzan, Michael" uniqKey="Farzan M" first="Michael" last="Farzan">Michael Farzan</name><affiliation><nlm:aff id="embj7600640-aff-0001"></nlm:aff></affiliation></author></analytic><series><title level="j">The EMBO Journal</title><idno type="ISSN">0261-4189</idno><idno type="eISSN">1460-2075</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Binding Sites</term><term>Carboxypeptidases (chemistry)</term><term>Carboxypeptidases (genetics)</term><term>Carboxypeptidases (metabolism)</term><term>Catalytic Domain</term><term>Disease Outbreaks</term><term>Humans</term><term>Membrane Glycoproteins (metabolism)</term><term>Models, Molecular</term><term>Molecular Sequence Data</term><term>Peptidyl-Dipeptidase A</term><term>Protein Binding</term><term>Protein Structure, Tertiary</term><term>Rats</term><term>Recombinant Fusion Proteins (genetics)</term><term>Recombinant Fusion Proteins (metabolism)</term><term>SARS Virus (metabolism)</term><term>Sequence Alignment</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Spike Glycoprotein, Coronavirus</term><term>Viral Envelope Proteins (metabolism)</term><term>Viverridae (virology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Alignement de séquences</term><term>Animaux</term><term>Carboxypeptidases ()</term><term>Carboxypeptidases (génétique)</term><term>Carboxypeptidases (métabolisme)</term><term>Domaine catalytique</term><term>Données de séquences moléculaires</term><term>Flambées de maladies</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires (métabolisme)</term><term>Humains</term><term>Liaison aux protéines</term><term>Modèles moléculaires</term><term>Peptidyl-Dipeptidase A</term><term>Protéines de fusion recombinantes (génétique)</term><term>Protéines de fusion recombinantes (métabolisme)</term><term>Protéines de l'enveloppe virale (métabolisme)</term><term>Rats</term><term>Sites de fixation</term><term>Structure tertiaire des protéines</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Séquence d'acides aminés</term><term>Virus du SRAS (métabolisme)</term><term>Viverridae (virologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Carboxypeptidases</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Carboxypeptidases</term><term>Recombinant Fusion Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Carboxypeptidases</term><term>Membrane Glycoproteins</term><term>Recombinant Fusion Proteins</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Carboxypeptidases</term><term>Protéines de fusion recombinantes</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Carboxypeptidases</term><term>Glycoprotéines membranaires</term><term>Protéines de fusion recombinantes</term><term>Protéines de l'enveloppe virale</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term><term>Viverridae</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term><term>Viverridae</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Binding Sites</term><term>Catalytic Domain</term><term>Disease Outbreaks</term><term>Humans</term><term>Models, Molecular</term><term>Molecular Sequence Data</term><term>Peptidyl-Dipeptidase A</term><term>Protein Binding</term><term>Protein Structure, Tertiary</term><term>Rats</term><term>Sequence Alignment</term><term>Spike Glycoprotein, Coronavirus</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Alignement de séquences</term><term>Animaux</term><term>Carboxypeptidases</term><term>Domaine catalytique</term><term>Données de séquences moléculaires</term><term>Flambées de maladies</term><term>Glycoprotéine de spicule des coronavirus</term><term>Humains</term><term>Liaison aux protéines</term><term>Modèles moléculaires</term><term>Peptidyl-Dipeptidase A</term><term>Rats</term><term>Sites de fixation</term><term>Structure tertiaire des protéines</term><term>Séquence d'acides aminés</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Human angiotensin‐converting enzyme 2 (ACE2) is a functional receptor for SARS coronavirus (SARS‐CoV). Here we identify the SARS‐CoV spike (S)‐protein‐binding site on ACE2. We also compare S proteins of SARS‐CoV isolated during the 2002–2003 SARS outbreak and during the much less severe 2003–2004 outbreak, and from palm civets, a possible source of SARS‐CoV found in humans. All three S proteins bound to and utilized palm‐civet ACE2 efficiently, but the latter two S proteins utilized human ACE2 markedly less efficiently than did the S protein obtained during the earlier human outbreak. The lower affinity of these S proteins could be complemented by altering specific residues within the S‐protein‐binding site of human ACE2 to those of civet ACE2, or by altering S‐protein residues 479 and 487 to residues conserved during the 2002–2003 outbreak. Collectively, these data describe molecular interactions important to the adaptation of SARS‐CoV to human cells, and provide insight into the severity of the 2002–2003 SARS epidemic.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E62 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000E62 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= PMC:1142572
|texte= Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:15791205" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |